When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study

Anne-Pascale Meert,Anne-Claire Toffart,Muriel Picard,Paul Jaubert,Aude Gibelin,Philippe Bauer,Djamel Mokart,Andry Van De Louw,Stefan Hatzl,Gabriel Moreno-Gonzales,Gaelle Rousseau-Bussac,Fabrice Bruneel,Luca Montini,Anne-Sophie Moreau,Dorothée Carpentier,Amelie Seguin,Pleun Hemelaar,Elie Azoulay,Virginie Lemiale

Bulletin du Cancer（2022）

引用 2|浏览19

暂无评分

摘要

Adverse events related to targeted therapy accounted for 20% of ICU admission in our population and carried a 16% one-month mortality. Outcome was associated with admission for TT related to adverse event, breast cancer and good performance status.

查看译文

关键词

Solid tumours,ICU,Adverse event,Targeted therapy,Outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要